| Bioactivity | MAGE-A1-derived peptide is a short peptide sequence derived from MAGE-A1 protein. As a tumor-specific antigen, MAGE-A1-derived peptide can be recognized and activated by cytotoxic T lymphocytes (CTLs), thereby generating an immune response to tumor cells expressing MAGE-A1. This immune response can lead to the lysis and death of tumor cells. MAGE-A1-derived peptide can be used in the study of tumor immunity[1]. |
| CAS | 160213-30-9 |
| Sequence | Lys-Val-Leu-Glu-Tyr-Val-Ile-Lys-Val |
| Shortening | KVLEYVIKV |
| Formula | C53H91N11O13 |
| Molar Mass | 1090.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ottaviani S, et al. A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells[J]. Cancer Immunology, Immunotherapy, 2005, 54: 1214-1220. |
MAGE-A1-derived peptide
CAS: 160213-30-9 F: C53H91N11O13 W: 1090.36
MAGE-A1-derived peptide is a short peptide sequence derived from MAGE-A1 protein. As a tumor-specific antigen, MAGE-A1-d
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.